$CATX
Perspective Therapeutics, Inc.

2019 Q4 Form 10-Q Financial Statement

#000143774919022693 Filed on November 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $2.206M $2.315M $1.562M
YoY Change 15.86% 48.21% 28.98%
Cost Of Revenue $1.095M $1.079M $1.038M
YoY Change -3.86% 3.95% 9.73%
Gross Profit $1.111M $1.236M $524.0K
YoY Change 45.23% 135.88% 97.74%
Gross Profit Margin 50.36% 53.39% 33.55%
Selling, General & Admin $1.737M $1.912M $1.622M
YoY Change -3.66% 17.88% 11.48%
% of Gross Profit 156.35% 154.69% 309.54%
Research & Development $277.0K $233.0K $420.0K
YoY Change -33.09% -44.52% 16.02%
% of Gross Profit 24.93% 18.85% 80.15%
Depreciation & Amortization $48.00K $38.00K $32.00K
YoY Change -4.0% 18.75% 77.78%
% of Gross Profit 4.32% 3.07% 6.11%
Operating Expenses $2.014M $2.072M $2.042M
YoY Change -8.2% 1.47% 12.38%
Operating Profit -$903.0K -$836.0K -$1.518M
YoY Change -36.81% -44.93% -2.19%
Interest Expense $6.000K $20.00K $10.00K
YoY Change -60.0% 100.0% 0.0%
% of Operating Profit
Other Income/Expense, Net $6.000K $20.00K $10.00K
YoY Change -60.0% 100.0% 66.67%
Pretax Income -$897.0K -$816.0K -$1.510M
YoY Change -36.56% -45.96% -2.58%
Income Tax
% Of Pretax Income
Net Earnings -$897.0K -$816.0K -$1.508M
YoY Change -36.56% -45.89% -2.46%
Net Earnings / Revenue -40.66% -35.25% -96.54%
Basic Earnings Per Share
Diluted Earnings Per Share -$13.31K -$12.11K -$22.83K
COMMON SHARES
Basic Shares Outstanding 67.39M 67.39M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.180M $4.575M $9.190M
YoY Change -59.58% -50.22% 26.58%
Cash & Equivalents $3.180M $4.575M $2.193M
Short-Term Investments $7.000M
Other Short-Term Assets $497.0K $209.0K $520.0K
YoY Change 41.6% -59.81% 26.83%
Inventory $545.0K $501.0K $487.0K
Prepaid Expenses
Receivables $1.409M $1.521M $1.070M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.631M $6.806M $11.27M
YoY Change -42.66% -39.6% 27.09%
LONG-TERM ASSETS
Property, Plant & Equipment $1.736M $1.669M $1.394M
YoY Change 18.01% 19.73% 27.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $142.0K $151.0K $185.0K
YoY Change -17.92% -18.38% -14.75%
Total Long-Term Assets $3.302M $3.318M $2.076M
YoY Change 57.91% 59.83% 8.41%
TOTAL ASSETS
Total Short-Term Assets $5.631M $6.806M $11.27M
Total Long-Term Assets $3.302M $3.318M $2.076M
Total Assets $8.933M $10.12M $13.34M
YoY Change -25.0% -24.13% 23.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $632.0K $984.0K $1.170M
YoY Change -47.16% -15.9% 44.44%
Accrued Expenses $708.0K $682.0K $470.0K
YoY Change 59.46% 45.11% 80.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.340M $1.666M $1.637M
YoY Change -18.29% 1.77% 53.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.452M $1.503M $600.0K
YoY Change 139.6% 150.5% 5.26%
Total Long-Term Liabilities $1.452M $1.503M $600.0K
YoY Change 139.6% 150.5% 5.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.340M $1.666M $1.637M
Total Long-Term Liabilities $1.452M $1.503M $600.0K
Total Liabilities $2.792M $3.169M $2.235M
YoY Change 24.31% 41.79% 36.7%
SHAREHOLDERS EQUITY
Retained Earnings -$86.21M -$85.31M -$80.86M
YoY Change 4.78% 5.51% 9.04%
Common Stock $92.35M $92.26M $91.97M
YoY Change 0.45% 0.32% 10.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.141M $6.955M $11.11M
YoY Change
Total Liabilities & Shareholders Equity $8.933M $10.12M $13.34M
YoY Change -25.0% -24.13% 23.77%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$897.0K -$816.0K -$1.508M
YoY Change -36.56% -45.89% -2.46%
Depreciation, Depletion And Amortization $48.00K $38.00K $32.00K
YoY Change -4.0% 18.75% 77.78%
Cash From Operating Activities -$1.278M -$653.0K -$1.612M
YoY Change 14.52% -59.49% -2.95%
INVESTING ACTIVITIES
Capital Expenditures -$106.0K $98.00K $114.0K
YoY Change -7.83% -14.04% 111.11%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$6.180M
YoY Change -100.0% -100.0% 2276.92%
Cash From Investing Activities -$106.0K -$98.00K -$6.289M
YoY Change -104.72% -98.44% 1896.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $7.494M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.00K 7.494M
YoY Change -90.83%
NET CHANGE
Cash From Operating Activities -1.278M -653.0K -1.612M
Cash From Investing Activities -106.0K -98.00K -6.289M
Cash From Financing Activities -11.00K 7.494M
Net Change In Cash -1.395M -751.0K -407.0K
YoY Change -237.98% 84.52% -79.4%
FREE CASH FLOW
Cash From Operating Activities -$1.278M -$653.0K -$1.612M
Capital Expenditures -$106.0K $98.00K $114.0K
Free Cash Flow -$1.172M -$751.0K -$1.726M
YoY Change 17.08% -56.49% 0.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 dei Amendment Flag
AmendmentFlag
false
CY2019Q3 isr Accrued Payroll And Related Taxes Current
AccruedPayrollAndRelatedTaxesCurrent
194000
CY2019Q2 isr Accrued Payroll And Related Taxes Current
AccruedPayrollAndRelatedTaxesCurrent
89000
CY2019Q3 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
73000
CY2018Q3 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
CY2019Q3 isr Increase Decrease In Accrued Payroll And Related Taxes
IncreaseDecreaseInAccruedPayrollAndRelatedTaxes
105000
CY2018Q3 isr Increase Decrease In Accrued Payroll And Related Taxes
IncreaseDecreaseInAccruedPayrollAndRelatedTaxes
-30000
CY2019Q3 isr Increase Decrease In Accrued Protocol Expense
IncreaseDecreaseInAccruedProtocolExpense
-108000
CY2018Q3 isr Increase Decrease In Accrued Protocol Expense
IncreaseDecreaseInAccruedProtocolExpense
48000
CY2019Q3 isr Increase Decrease In Accrued Vacation
IncreaseDecreaseInAccruedVacation
13000
CY2018Q3 isr Increase Decrease In Accrued Vacation
IncreaseDecreaseInAccruedVacation
-1000
CY2019Q3 isr Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-54000
CY2019Q3 isr Noncash Financing Activities Warrants Issued
NoncashFinancingActivitiesWarrantsIssued
CY2018Q3 isr Noncash Financing Activities Warrants Issued
NoncashFinancingActivitiesWarrantsIssued
163000
CY2019Q3 isr Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
55000
CY2015Q4 isr Purchase Agreement Period
PurchaseAgreementPeriod
P1Y
CY2019Q3 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
CY2018Q3 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
26000
CY2019Q3 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
233000
CY2018Q3 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
394000
CY2019Q3 isr Restocking Fee Percentage
RestockingFeePercentage
0.5
CY2019Q3 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
3000
CY2018Q3 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
35000
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
984000
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
683000
CY2019Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
25000
CY2019Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
133000
CY2019Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
155000
CY2019Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
142000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7408000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7370000
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
92196000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
92105000
CY2019Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
11000
CY2018Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
12000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
93000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
91000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
91000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10760000
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9933000
CY2019Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
555000
CY2019Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
621000
CY2018Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
590000
CY2018Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
598000
CY2019Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
7000
CY2018Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
8000
CY2019Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
555000
CY2019Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
621000
CY2019Q3 us-gaap Assets
Assets
10124000
CY2019Q2 us-gaap Assets
Assets
9422000
CY2019Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2019Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019Q3 dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
CY2019Q3 dei Document Type
DocumentType
10-Q
CY2019Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000728387
CY2019Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q3 dei Entity Registrant Name
EntityRegistrantName
IsoRay, Inc.
CY2019Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q3 dei Trading Symbol
TradingSymbol
isr
CY2019Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67388047
CY2019Q3 dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Security12b Title
Security12bTitle
Common stock
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4575000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5326000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2193000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5507000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
6806000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
7315000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2781000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4756000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2374000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-751000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-407000
CY2018Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5830000
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67388047
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67388047
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67388047
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67388047
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
67000
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
67000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1079000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1038000
CY2019Q3 us-gaap Depreciation
Depreciation
38000
CY2018Q3 us-gaap Depreciation
Depreciation
32000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
537000
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P357D
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1097000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
973000
CY2019Q3 us-gaap Gross Profit
GrossProfit
1236000
CY2018Q3 us-gaap Gross Profit
GrossProfit
524000
CY2019Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
301000
CY2018Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-224000
CY2019Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
367000
CY2018Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-121000
CY2019Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-39000
CY2018Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10000
CY2019Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
9000
CY2018Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
9000
CY2019Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-97000
CY2018Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
182000
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10000
CY2019Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
31000
CY2019Q3 us-gaap Inventory Net
InventoryNet
501000
CY2019Q2 us-gaap Inventory Net
InventoryNet
530000
CY2019Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
145000
CY2019Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
155000
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
330000
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
333000
CY2019Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
161000
CY2019Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
166000
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
20000
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1324000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
237000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
290000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
290000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
290000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
217000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
151000
CY2019Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019Q3 us-gaap Liabilities
Liabilities
3169000
CY2019Q2 us-gaap Liabilities
Liabilities
1742000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10124000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9422000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1666000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1121000
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2018Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7494000
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98000
CY2018Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6289000
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-653000
CY2018Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1612000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-816000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1508000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-819000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1511000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
20000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
2072000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
2042000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-836000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1518000
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
73000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1173000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
225000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
948000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1172000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y182D
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
151000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
162000
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
83000
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
74000
CY2019Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
98000
CY2018Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
114000
CY2019Q3 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
CY2018Q3 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
6750000
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000
CY2018Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
209000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
305000
CY2019Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7494000
CY2019Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
CY2018Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
575000
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9077000
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8979000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1669000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1609000
CY2019Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
1521000
CY2019Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
1154000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
233000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
420000
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85308000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84492000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2315000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1562000
CY2019Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1228000
CY2018Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
815000
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
649000
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
91000
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
93000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2909000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.74
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
8250
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
10000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
26250
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
38750
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
82500
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4621000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.64
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4621000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.64
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y255D
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y335D
CY2018Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y255D
CY2019Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7494000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
6955000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
7680000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
5030000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
11109000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67388000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66147000

Files In Submission

Name View Source Status
0001437749-19-022693-index-headers.html Edgar Link pending
0001437749-19-022693-index.html Edgar Link pending
0001437749-19-022693.txt Edgar Link pending
0001437749-19-022693-xbrl.zip Edgar Link pending
ex_161073.htm Edgar Link pending
ex_161074.htm Edgar Link pending
ex_161075.htm Edgar Link pending
ex_161076.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20190930.xml Edgar Link completed
isr-20190930.xsd Edgar Link pending
isr-20190930_cal.xml Edgar Link unprocessable
isr-20190930_def.xml Edgar Link unprocessable
isr-20190930_lab.xml Edgar Link unprocessable
isr-20190930_pre.xml Edgar Link unprocessable
isr20190930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending